Publications

Breast cancer research and treatment

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile.

01-04-2021

Medical physics

Improving linac integrated cone beam computed tomography image quality using tube current modulation.

01-04-2021

Acta oncologica (Stockholm, Sweden)

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

01-04-2021

The Lancet. Oncology

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.

01-04-2021

Histopathology

RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.

01-04-2021

Molecular aspects of medicine

Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.

01-04-2021

ESMO open

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration.

01-04-2021

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

01-04-2021

Medical physics

Characterization of Gas Electron Multiplier-based detector for external beam radiation therapy dosimetry.

01-04-2021

Critical reviews in oncology/hematology

Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?

01-04-2021

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Professional patient navigation in a hospital setting: a randomized controlled trial.

01-04-2021

European journal of nuclear medicine and molecular imaging

Optimal ⁶⁸Ga-PSMA and ¹⁸F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.

01-04-2021

The Journal of molecular diagnostics : JMD

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

01-04-2021

The Journal of investigative dermatology

Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during Skin Carcinogenesis.

01-04-2021

Journal of cancer survivorship : research and practice

The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.

01-04-2021

Pediatric blood & cancer

Female reproductive function after treatment of childhood acute lymphoblastic leukemia.

01-04-2021

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib.

01-04-2021

ESMO open

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE).

01-04-2021

Cancer research

Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.

01-04-2021

Cancer immunology, immunotherapy : CII

Clinically applicable CD34⁺-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

01-04-2021

Hepatology international

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients.

01-04-2021

Current opinion in immunology

Modulation of the tumor micro-environment by CD8⁺ T cell-derived cytokines.

01-04-2021

Nature

Identification of bacteria-derived HLA-bound peptides in melanoma.

01-04-2021

Future oncology (London, England)

The intravenous to oral switch of taxanes: strategies and current clinical developments.

01-04-2021

Cancer research

Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.

01-04-2021

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.

01-04-2021

Nature medicine

COVID-19 vaccination: the VOICE for patients with cancer.

01-04-2021

The oncologist

Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.

01-04-2021

Nature structural & molecular biology

The selection process of licensing a DNA mismatch for repair.

01-04-2021

European urology

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy.

01-04-2021

The FEBS journal

Conserved residues Glu37 and Trp229 play an essential role in protein folding of β-lactamase.

31-03-2021

Frontiers in endocrinology

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.

30-03-2021

BMJ open

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).

30-03-2021

Cancer immunology, immunotherapy : CII

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

27-03-2021

BMC cancer

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

25-03-2021

International journal of epidemiology

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

23-03-2021

Physics in medicine and biology

Reducing 4DCBCT scan time and dose through motion compensated acquisition and reconstruction.

23-03-2021

Cancers

Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum.

22-03-2021

NPJ breast cancer

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.

22-03-2021

Prostate cancer and prostatic diseases

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.

21-03-2021

Frontiers in oncology

Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy.

20-03-2021

European radiology

Correction to: Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer.

19-03-2021

Human reproduction (Oxford, England)

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

18-03-2021

Journal of cancer survivorship : research and practice

Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.

17-03-2021

Bioinformatics (Oxford, England)

Ribo-ODDR: Oligo design pipeline for experiment-specific rRNA depletion in ribo-seq.

15-03-2021

EJNMMI research

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.

12-03-2021

Journal of the National Cancer Institute

Endometrial Cancer Risk in Women with Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

12-03-2021

Cancer reports (Hoboken, N.J.)

ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.

12-03-2021

Cells

Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence.

10-03-2021

Cancers

Subsequent Malignant Neoplasms in Retinoblastoma Survivors.

10-03-2021

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile.

Improving linac integrated cone beam computed tomography image quality using tube current modulation.

The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.

RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.

Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration.

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Characterization of Gas Electron Multiplier-based detector for external beam radiation therapy dosimetry.

Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?

Professional patient navigation in a hospital setting: a randomized controlled trial.

Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during Skin Carcinogenesis.

The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.

Female reproductive function after treatment of childhood acute lymphoblastic leukemia.

The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib.

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE).

Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.

Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients.

Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

Identification of bacteria-derived HLA-bound peptides in melanoma.

The intravenous to oral switch of taxanes: strategies and current clinical developments.

Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.

Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.

COVID-19 vaccination: the VOICE for patients with cancer.

Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.

The selection process of licensing a DNA mismatch for repair.

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy.

Conserved residues Glu37 and Trp229 play an essential role in protein folding of β-lactamase.

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

Reducing 4DCBCT scan time and dose through motion compensated acquisition and reconstruction.

Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum.

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.

Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy.

Correction to: Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer.

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.

Ribo-ODDR: Oligo design pipeline for experiment-specific rRNA depletion in ribo-seq.

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.

Endometrial Cancer Risk in Women with Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.

Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence.

Subsequent Malignant Neoplasms in Retinoblastoma Survivors.

This site uses cookies

Optimal ⁶⁸Ga-PSMA and ¹⁸F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.

Clinically applicable CD34⁺-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Modulation of the tumor micro-environment by CD8⁺ T cell-derived cytokines.